4 results match your criteria: "and Nagoya University School of Medicine[Affiliation]"
Levels of placenta growth factor in gestational trophoblastic diseases.
Am J Obstet Gynecol
January 2003
Department of Obstetrics and Gynecology, Chukyo Hospital, and Nagoya University School of Medicine, Nagoya, Japan.
Objective: The aim of the current study was to investigate levels of placenta growth factor in the tissues and sera of the patients with gestational trophoblastic disease and to determine its usefulness for the treatment of gestational trophoblastic disease.
Study Design: Placenta growth factor concentrations were measured in the tissue homogenates of 12 normal placentas, 33 complete hydatidiform moles, and 6 gestational choriocarcinomas. Serum placenta growth factor levels were determined in 59 women with normal pregnant course, in 30 women with complete hydatidiform mole, in 36 women with persistent gestational trophoblastic disease, and 100 nonpregnant healthy volunteers.
Growth fractions of human renal cell carcinoma defined by monoclonal antibody Ki-67. Predictive values for prognosis.
Int J Urol
November 2001
Department of Urology, Komaki Shimin Hospital, Chubu National Hospital/National Institute For Longevity Science and Nagoya University School of Medicine, Nagoya, Japan.
Background: We used immunohistochemical techniques to elucidate the role of growth fractions of renal cell carcinoma in the clinicopathology of the condition and patient survival.
Methods: Fifty-two fresh-frozen nephrectomy specimens were immunostained with Ki-67 monoclonal antibody. Ki-67 indexes were determined to examine the relationship between tumor size, grade, stage and survival curve.
Alveolar ridge augmentation with titanium mesh and autogenous bone.
Oral Surg Oral Med Oral Pathol Oral Radiol Endod
March 2000
The National Chubu Hospital, National Institute for Longevity Sciences, and Nagoya University School of Medicine, Japan.